Obesity Increased in Adults But Not Youth in Last Ten Years

MedicalResearch.com Interview with:
Craig M. Hales, MD Cheryl D. Fryar, MSPH; Margaret D. Carroll, MSPH; David S. Freedman, PhD; Cynthia L. Ogden, PhD

National Center for Health Statistics
National Center for Chronic Disease Prevention and Health Promotion
US Centers for Disease Control and Prevention
Atlanta, Georgia

MedicalResearch.com: What is the background for this study? What are the main findings?

Response: In this analysis we examined recent trends in the prevalence of obesity and severe obesity among both youth and adults, by sex and age group.

Among adults, obesity and severe obesity prevalence has increased over the last 10 years.  Obesity prevalence increased from 33.7% in 2007-2008 to 39.6% or almost 40% in 2015-2016, and severe obesity increased from 5.7% in 2007-2008 to 7.7% in 2015-2016.  We see this same pattern of increasing prevalence of obesity and severe obesity in both men and women, and in different age groups.

On the other hand, among youth, we saw no increasing or decreasing trends in obesity or severe obesity prevalence over the 10 year period.  And this was true for both boys and girls and for different age groups.

Measured height and weight is the gold standard for generating accurate estimates of obesity prevalence.  The National Health and Nutrition Examination Survey is unique in that it combines both interviews in the home and physical examinations in mobile examination centers, and it is the only national survey where people’s height and weight are physically measured.  This is why NHANES is such an important source of data for understanding trends in obesity in youth and adults. 

Citations: 

Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016. JAMA. Published online March 23, 2018. doi:10.1001/jama.2018.3060

 

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.

Weight Gain Causes Loss of Taste Buds and Flavor Intensity

MedicalResearch.com Interview with:

Robin Dando, PhD Assistant Professor Director, Cornell Sensory Evaluation Facility Department of Food Science Cornell University Ithaca, NY 14853

Dr. Dando

Robin Dando, PhD
Assistant Professor
Director, Cornell Sensory Evaluation Facility
Department of Food Science
Cornell University
Ithaca, NY 14853

MedicalResearch.com: What is the background for this study? What are the main findings? 

Response: For many years, people have been interested in if gaining weight can change how we perceive foods, thus maybe encouraging less healthy food choices.  There is some evidence in previous work that if we become obese, we seem to perceive things as tasting less intense.  Now if this were the case, to make up for this we might eat more of whatever food it was we were eating, or conversely we might choose something that tasted more intense, to make up this difference.  More intense usually means higher calories, so if we took either of these approaches, we’re at risk for weight gain.

In our study, we examined the taste buds of mice who were fed an unhealthy diet that induces obesity, versus sibling mice fed a more healthy diet that keeps them lean.  The mice gaining weight ended up after only 8 weeks with a lot fewer taste buds than the lean mice.  This loss of taste buds represents one explanation for foods tasting less intense to the obese.

Continue reading

Endocrine Disrupter PFAS Chemicals Linked To Weight Regain, Especially in Women

MedicalResearch.com Interview with:

Gang Liu, PhD Postdoctoral Research Fellow Department of Nutrition Harvard T.H. Chan School of Public Health

Dr. Gang Liu

Gang Liu, PhD
Postdoctoral Research Fellow
Department of Nutrition
Harvard T.H. Chan School of Public Health 

MedicalResearch.com: What is the background for this study? What are the main findings?

Response: Although many approaches can be used to achieve a short-term weight loss, maintenance of weight loss has become a key challenge for sustaining long-term benefits of weight loss. Accumulating evidence has suggested that certain environmental compounds may play an important role in weight gain and obesity development.

The potential endocrine-disrupting effects of perfluoroalkyl substances (PFASs), which are extensively used in many industrial and consumer products including food packaging, paper and textile coatings, and non-stick cookware, have been demonstrated in animal studies, but whether PFASs may interfere with body weight regulation in humans is largely unknown.

In a 2-year POUNDS Lost randomized clinical trial that examined energy-restricted diets on weight changes, baseline plasma concentrations of major PFASs were measured among 621 overweight and obese participants aged 30-70 years. Body weight was measured at baseline, 6, 12, 18, and 24 months. Resting metabolic rate (RMR) and other metabolic parameters, including glucose, lipids, thyroid hormones, and leptin, were measured at baseline, 6, and 24 months.

We found that higher baseline levels of PFASs were significantly associated with a greater weight regain, primarily in women. On average, women in the highest tertile of PFASs regained 1.7-2.2 kg more body weight than women in the lowest tertile. In addition, higher baseline plasma PFAS concentrations, especially perfluorooctanesulfonic acid (PFOS) and perfluorononanoic acid (PFNA), were significantly associated with greater decline in RMR during the first 6 months and less increase in RMR during weight regain period.  Continue reading

Sugar-Sweetened Beverages Play Large Role In Worldwide Obesity Epidemic

MedicalResearch.com Interview with:
“Soda” by Jannes Pockele is licensed under CC BY 2.0Maria Luger, MSc
SIPCAN
Special Institute for Preventive Cardiology And Nutrition
Spendenbegünstigte Einrichtung gem. FW 1914/19.3.2005
Vorstand: Univ.-Prof. Prim. Dr. Friedrich Hoppichler
Salzburg, Austria

MedicalResearch.com: What is the background for this study?

Response: Worldwide obesity has nearly tripled since 1975. Rising consumption of sugar-sweetened beverages (SSBs) has been a major contributor to the obesity epidemic and it increases the risk of diabetes or cardiovascular disease, as previous evidence has shown. Partly inconsistent findings from previous reviews have fueled discussions on the impact of SSBs on obesity development.

Therefore, the aim of our review was to systematically review the recent evidence in children and adults.

Continue reading

No Mortality Benefit From Weight Gain in Rheumatoid Arthritis

MedicalResearch.com Interview with:

Jeffrey A. Sparks, M.D., M.M.Sc. Assistant Professor of Medicine Division of Rheumatology, Immunology and Allergy Department of Medicine Brigham and Women’s Hospital Harvard Medical School

Dr. Sparks

Jeffrey A. Sparks, M.D., M.M.Sc.
Assistant Professor of Medicine
Division of Rheumatology, Immunology and Allergy
Department of Medicine
Brigham and Women’s Hospital
Harvard Medical School

MedicalResearch.com: What is the background for this study? What are the main findings?

Response: We compared women diagnosed with rheumatoid arthritis (RA) during follow-up in the Nurses’ Health Study and matched women without RA during the same index time period. Women with RA had higher mortality than women without RA. In both groups, those that had severe weight loss (>30 pounds), had the highest mortality after the early RA/index period. Weight gain in the early RA period was not associated with mortality for either group.

Continue reading

Overeating High-Fructose Corn Syrup Can Raise Both Hunger and Cortisol Levels

MedicalResearch.com Interview with:
“Herring in high fructose corn syrup” by Ray Sawhill is licensed under CC BY 2.0Paolo Piaggi PhD and
Marie Thearle MD
Phoenix Epidemiology and Clinical Research Branch
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Phoenix, Arizona 

MedicalResearch.com: What is the background for this study? What are the main findings?

Response: Changes in food preparation have occurred over the recent decades including wide-spread availability of convenience foods and use of fructose as a sweetener. In addition, there is a growing trend to label certain foods as “healthy”. As the ingestion of added sugars and the prevalence of obesity have steadily increased over time, it has been suggested that the increased consumption of simple sugars may have contributed to the recent obesity epidemic.

We were interested in understanding whether the body responded to overeating foods with a high carbohydrate content differently if the source of the carbohydrate differed. For example, does it matter if we overeat foods containing whole wheat instead of high-fructose corn syrup? To answer this question, we conducted a study investigating changes in metabolism, circulating hormones, and appetite ratings in humans who were overfed a diet containing 75% carbohydrates for 24 hours. The subjects in the study were overfed with a high carbohydrate diet twice – once with a diet where the source of carbohydrates was whole wheat and once with a diet that contained simple sugars, primarily high-fructose corn syrup (HFCS). Note that the diets were given in random order with at least three days of recovery in between the overfeeding periods.

There was no difference in people’s metabolic rate over 24 hours between the whole-wheat versus high-fructose corn syrup diets; however, the diet containing HFCS resulted in increased hunger scores the next morning even though people had overeaten the day prior. These increased hunger scores were comparable to the hunger scores reported after a day of fasting. Also, 24-hour urinary free cortisol concentrations were higher the day after the diet containing high-fructose corn syrup. Cortisol is a hormone released by the adrenal glands in response to physiologic stress.

Continue reading

Weight Gain Early In Pregnancy Linked To Higher Birthweight Babies

MedicalResearch.com Interview with:

Leanne M. Redman MS, PhD LPFA Endowed Fellowship Associate Professor Pennington Biomedical Research Center Baton Rouge, Louisiana

Dr. Redman

Leanne M. Redman MS, PhD
LPFA Endowed Fellowship
Associate Professor
Pennington Biomedical Research Center
Baton Rouge, Louisiana 

MedicalResearch.com: What is the background for this study? What are the main findings?

Response: Two well-documented risk factors for aberrant weight gain and obesity is whether your mother was obese when she was pregnant and the amount of weight she gained.

Up until now few studies have asked questions about whether the pattern of weight gain in pregnancy affect outcomes in offspring, such as birth weight.

In a cohort of over 16,000 pregnant women and infants, we found that regardless of the obesity status (BMI) of the mother at the time of pregnancy, weight gain that occurs up until week 24, had the strongest effect on infant birth weight. Infants born to mothers who had weight gain in excess of the 2009 IOM guidelines from conception until week 24, had a 2.5 times higher likelihood of being born large for gestational age. The weight gain that occurred after 24 weeks until delivery, did not attenuate this risk.

Continue reading

Serotonin Receptors Tied To Weight Gain From Atypical Antipsychotic Medications

MedicalResearch.com Interview with:

Chen Liu, Ph.D. Assistant Professor Departments of Internal Medicine and Neuroscience Division of Hypothalamic Research The University of Texas Southwestern Medical Center Dallas, Texas 75390-9077

Dr. Chen Liu

Chen Liu, Ph.D.
Assistant Professor
Departments of Internal Medicine and Neuroscience
Division of Hypothalamic Research
The University of Texas Southwestern Medical Center
Dallas, Texas 75390-9077 

MedicalResearch.com: What is the background for this study?

Response: Atypical antipsychotics are second-generation antipsychotics (SGAs) that have been increasingly used to treat a variety of neuropsychiatric conditions such as schizophrenia, depression, and autism. Many patients taking these medications, however, are left in an agonizing dilemma.

On one hand, they rely on these drugs’ psychotropic effect for normal functioning in daily life. On the other, many SGAs, including the most widely prescribed olanzapine and clozapine, can cause a metabolic syndrome that is known for excessive weight gain, dyslipidemia, and type-2 diabetes_ENREF_2. Notably, while full-blown type 2 diabetes and morbid obesity typically take years to unfold in the general population, these conditions progress at a much faster pace (within months) following second-generation antipsychotics treatment. Other factors such as ethnicity, age, and sex can also aggravate SGA-induced metabolic syndrome. Together, these peculiar features strongly suggest a distinct etiology underlying SGA-induced metabolic syndrome that has yet been fully elucidated. Currently, there is no medication specifically targeting SGA-induced metabolic syndrome. For many youths and adults taking second-generation antipsychotics, metabolic complications are difficult to manage as lifestyle changes, nutritional consulting, and commonly used anti-diabetic medications only provide limited relief.

Continue reading

Physical Activity Not Enough To Ward Off Weight Gain

MedicalResearch.com Interview with:

Lara Dugas, PhD, MPH, FTOS Public Health Sciences Loyola University Chica

Dr. Lara Dugas

Lara Dugas, PhD, MPH, FTOS
Public Health Sciences
Loyola University Chicago

MedicalResearch.com: What is the background for this study?

Response: Our NIH-funded study is led by Dr. Amy Luke, Public Health Sciences, Loyola University Chicago, and is titled “Modeling the Epidemiologic Transition study” or METS. It was initiated in 2010, and 2,500 young African-origin adults were recruited from 5 countries, spanning the Human Development Index (HDI), a WHO index used to rank countries according to 4 tiers of development. The 5 countries include the US, Seychelles, Jamaica, South Africa, and Ghana. Within each country 500 young adults, 25-45 yrs., and 50% male, were recruited and followed prospectively for 3 years. Each year, contactable participants completed a health screening, body composition, wore an activity monitor for 7 days, and told researchers everything they had eaten in the preceding 24hrs. Our main research questions we were trying to answer were to understand the impact of diet and physical activity on the development of obesity, and cardiovascular disease in young adults. It was important to have countries spanning the HDI, with differences in both country-level dietary intake and physical activity levels.

Continue reading

Newly Identified Molecule Turns Fat Storage Gene Off

MedicalResearch.com Interview with:

Prof. Jamal Tazi Institut de Génétique Moléculaire de Montpellier University of Montpellier Montpellier, Cedex, France

Prof. Jamal Tazi

Prof. Jamal Tazi
Institut de Génétique Moléculaire de Montpellier
University of Montpellier
Montpellier, Cedex, France

MedicalResearch.com: What is the background for this study? What are the main findings?

Response: Intense drug discovery efforts in the metabolic field highlight the need for novel strategies for the treatment of obesity. In this study we have used a novel approach to uncover novel drugs to treat obesity. Our approach is based on the finding that in humans the energy expenditure balance can be controlled by a single gene LMNA gene that can produce two different proteins with opposing effect on energy expenditure. We identified a molecule ABX300 that targets the expression of LMNA gene and favors energy expenditure leading to fat loss.

Continue reading